1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Sanofi

Anonymous board for Sanofi.


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    0
    Views:
    60
  2. anonymous
    Replies:
    5
    Views:
    1,082
  3. anonymous
    Replies:
    10
    Views:
    988
  4. anonymous
    Replies:
    13
    Views:
    2,219
  5. anonymous
    Replies:
    8
    Views:
    472
  6. anonymous
    Replies:
    2
    Views:
    558
  7. anonymous
    Replies:
    2
    Views:
    199
  8. anonymous
    Replies:
    17
    Views:
    4,482
  9. anonymous
    Replies:
    1
    Views:
    491
  10. TexasAM
    Replies:
    1
    Views:
    345
  11. anonymous
    Replies:
    4
    Views:
    1,585
  12. anonymous
    Replies:
    3
    Views:
    598
  13. anonymous
    Replies:
    17
    Views:
    2,375
  14. anonymous
    Replies:
    0
    Views:
    528
  15. anonymous
    Replies:
    3
    Views:
    1,149
  16. anonymous
    Replies:
    9
    Views:
    1,818
  17. anonymous
    Replies:
    2
    Views:
    693
  18. anonymous
    Replies:
    8
    Views:
    1,560
  19. anonymous
    Replies:
    21
    Views:
    4,443
  20. anonymous
    Replies:
    3
    Views:
    904

Thread Display Options

Loading...